DENISE NEBGEN

TitleAssociate Professor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Nebgen DR, Lu KH, Bast RC. Novel Approaches to Ovarian Cancer Screening. Curr Oncol Rep. 2019 07 26; 21(8):75. PMID: 31346778.
      Citations: 5     Fields:    Translation:Humans
    2. Rayes N, Bowen DJ, Coffin T, Nebgen D, Peterson C, Munsell MF, Gavin K, Lechner R, Crase J, Polinsky D, Romero I, Blank SV, Levine DA, Norquist BM, Swisher EM, Lu KH. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing. BMC Cancer. 2019 Jul 02; 19(1):648. PMID: 31266460.
      Citations: 5     Fields:    Translation:Humans
    3. Sun CC, Meyer LA, Daniels MS, Bodurka DC, Nebgen DR, Burton-Chase AM, Lu KH, Peterson SK. Women's preferences for cancer risk management strategies in Lynch syndrome. Gynecol Oncol. 2019 03; 152(3):514-521. PMID: 30876497.
      Citations: 2     Fields:    Translation:Humans
    4. Nebgen DR, Hurteau J, Holman LL, Bradford A, Munsell MF, Soletsky BR, Sun CC, Chisholm GB, Lu KH. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations. Gynecol Oncol. 2018 07; 150(1):79-84. PMID: 29735278.
      Citations: 12     Fields:    Translation:Humans
    5. Yates MS, Coletta AM, Zhang Q, Schmandt RE, Medepalli M, Nebgen D, Soletsky B, Milbourne A, Levy E, Fellman B, Urbauer D, Yuan Y, Broaddus RR, Basen-Engquist K, Lu K. Prospective Randomized Biomarker Study of Metformin and Lifestyle Intervention for Prevention in Obese Women at Increased Risk for Endometrial Cancer. Cancer Prev Res (Phila). 2018 08; 11(8):477-490. PMID: 29716897.
      Citations: 4     Fields:    Translation:Humans
    6. Nebgen DR, Rhodes HE, Hartman C, Munsell MF, Lu KH. Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer. Obstet Gynecol. 2016 08; 128(2):357-363. PMID: 27400009.
      Citations: 1     Fields:    Translation:Humans
    7. Streff H, Profato J, Ye Y, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers. Oncologist. 2016 07; 21(7):869-74. PMID: 27306910.
      Citations: 16     Fields:    Translation:Humans
    8. Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015 Jan 15; 121(2):269-75. PMID: 25224030.
      Citations: 119     Fields:    Translation:Humans
    9. Nebgen DR, Lu KH, Rimes S, Keeler E, Broaddus R, Munsell MF, Lynch PM. Combined colonoscopy and endometrial biopsy cancer screening results in women with Lynch syndrome. Gynecol Oncol. 2014 Oct; 135(1):85-9. PMID: 25149916.
      Citations: 3     Fields:    Translation:Humans
    10. Bercaw-Pratt JL, Santos XM, Sanchez J, Ayensu-Coker L, Nebgen DR, Dietrich JE. The incidence, attitudes and practices of the removal of pubic hair as a body modification. J Pediatr Adolesc Gynecol. 2012 Feb; 25(1):12-4. PMID: 22088314.
      Citations: 8     Fields:    Translation:Humans
    11. Nebgen DR, Inoue H, Sabsay B, Wei K, Ho CS, Veis A. Identification of the chondrogenic-inducing activity from bovine dentin (bCIA) as a low-molecular-mass amelogenin polypeptide. J Dent Res. 1999 Sep; 78(9):1484-94. PMID: 10512382.
      Citations: 15     Fields:    Translation:AnimalsCells
    12. Inoue H, Nebgen D, Veis A. Changes in phenotypic gene expression in rat mandibular condylar cartilage cells during long-term culture. J Bone Miner Res. 1995 Nov; 10(11):1691-7. PMID: 8592945.
      Citations: 3     Fields:    Translation:AnimalsCells
    13. DiPietro LA, Nebgen DR, Polverini PJ. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J Vasc Res. 1994 May-Jun; 31(3):178-85. PMID: 7511943.
      Citations: 27     Fields:    Translation:AnimalsCells
    14. Nebgen D, Wood RS, Shapiro RD. Management of a mandibular fracture in a patient with cleidocranial dysplasia: report of a case and review of the literature. J Oral Maxillofac Surg. 1991 Apr; 49(4):405-9. PMID: 2005496.
      Citations: 2     Fields:    Translation:Humans
    15. Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer. Obstetrics and Gynecology. 128:357-363.
    16. Cancer incidence in first- and second-degree relatives of BRCA1 and BRCA2 mutation carriers. Oncologist. 21:869-874.
    17. Erratum. Cancer. 121:2474-2475.
    NEBGEN's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (143)
    Explore
    _
    Co-Authors (18)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _